Dr. Vladimir Zelenko: Interview with Dr. Mercola

Note:  Interview actually begins at Minute 3

Story at-a-glance

  • As early as March 2020, Dr. Vladimir Zelenko boasted a near-100% success rate treating COVID-19 patients with hydroxychloroquine (HCQ), azithromycin and zinc sulfate for five days
  • Zelenko has now treated 3,000 patients with COVID-19 symptoms and only three high-risk patients have died
  • Misinformation and outright lies were spun about HCQ, including fabricated research, in an apparent effort to suppress and prevent widespread use
  • Early treatment is crucial. During the first five days of SARS-CoV-2 infection, the viral load remains fairly steady. Around Day 5, it exponentially increases, potentially overwhelming your immune system. To prevent complications, treatment needs to begin within the first five days of symptom onset
  • Early treatment is also crucial to prevent “long-haul” symptoms after recovery. None of Zelenko’s patients who started their treatment within the first five days went on to develop long-haul symptoms

Full Text of Interview

This entry was posted in 2021-2025, COVID Medications, COVID-19, HCQ. Bookmark the permalink.

1 Response to Dr. Vladimir Zelenko: Interview with Dr. Mercola

  1. Agretha206 says:

    Thank you for your post, I look for such article along time, today i find it finally. this post give me lots of advise it is very useful for me.

Leave a Reply

Your email address will not be published. Required fields are marked *